ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

May 29, 2009

In the States: Georgia Requires Coverage Of Routine Costs For Children In Clinical Trials

August 14, 1998

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

November 25, 1977

Southern Gets Two More Contracts Totaling 44.5 Million From NCI

June 14, 1974

ACS Board Approves Special Donors Concept, Oks New Program or Cause And Prevention Research

February 23, 1979